Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 81061

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 28, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Humco Holding Group, Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-8077-43 Packaged by: Humco Texarkana, TX 75501

D-0022-2019
Recall number
D-0022-2019
Initiated
August 28, 2018
Classification
Class II
Status
Terminated
Recalling firm
Humco Holding Group, Inc
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Code information

Lots: A24542 Exp. 02/2019; A25528 Exp. 04/2019; A27119 Exp. 05/2019; A27810 Exp. 06/2019

Distribution pattern

Nationwide.

drug · product 2 of 3

Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA

D-0023-2019
Recall number
D-0023-2019
Initiated
August 28, 2018
Classification
Class II
Status
Terminated
Recalling firm
Humco Holding Group, Inc
Quantity
Unknown.

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Code information

Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019

Distribution pattern

Nationwide.

drug · product 3 of 3

Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA

D-0024-2019
Recall number
D-0024-2019
Initiated
August 28, 2018
Classification
Class II
Status
Terminated
Recalling firm
Humco Holding Group, Inc
Quantity
10 kilograms

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Code information

Lot: A26450 Exp. 05/2019

Distribution pattern

Nationwide.